# GPi+NBM DBS in Parkinson's Disease With Mild Cognitive Impairment

> **NCT04571112** · NA · COMPLETED · sponsor: **University of Toronto** · enrollment: 6 (actual)

## Conditions studied

- Parkinson Disease
- Memory Disorders

## Interventions

- **DEVICE:** NBM stimulation using the Vercise device (Boston Scientific, Marlborough, Massachusetts, US)

## Key facts

- **NCT ID:** NCT04571112
- **Lead sponsor:** University of Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-04
- **Primary completion:** 2020-10-01
- **Final completion:** 2021-03-01
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04571112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04571112, "GPi+NBM DBS in Parkinson's Disease With Mild Cognitive Impairment". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04571112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*